Omslagafbeelding van de show Ozempic and the Food Industry — Who's Losing?

Ozempic and the Food Industry — Who's Losing?

Podcast door Inception Point AI

Engels

Technologie en Wetenschap

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode.Elk moment opzegbaar.

  • 20 uur luisterboeken / maand
  • Podcasts die je alleen op Podimo hoort
  • Gratis podcasts
Probeer gratis

Over Ozempic and the Food Industry — Who's Losing?

GLP-1 drugs like Ozempic are shrinking American appetites by up to a thousand calories daily, and entire industries are scrambling to survive. Host Nick Ledger tracks the money trail through snack aisles, alcohol sales, and drive-thrus as millions of consumers simply stop craving what built modern food empires. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle afleveringen

4 afleveringen

aflevering Ozempic and the Food Industry — Who's Losing? - The Drive-Thru Slowdown artwork

Ozempic and the Food Industry — Who's Losing? - The Drive-Thru Slowdown

Nick Ledger examines how GLP-1 weight loss medications are disrupting America's fast-food industry, with spending at drive-thrus dropping 8% as users consume fewer calories and crave nutrient-dense foods over burgers and fries. We discuss reported shifts in consumer behavior and the economic ripple effects reshaping restaurants, suppliers, and communities nationwide. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 27 min
aflevering Ozempic and the Food Industry — Who's Losing? - Last Call for the Bar Tab artwork

Ozempic and the Food Industry — Who's Losing? - Last Call for the Bar Tab

Nick Ledger examines how GLP-1 drugs like Ozempic are reshaping America's alcohol industry. Clinical studies show users reduce drinking by up to 66%, not through willpower but neurochemical changes that eliminate cravings. From craft breweries to dive bars, businesses built on repeat consumption face an unprecedented challenge as their highest-margin product becomes biologically unnecessary. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 22 min
Meld je aan om te luisteren
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Makkelijk in gebruik!
App ziet er mooi uit, navigatie is even wennen maar overzichtelijk.

Kies je abonnement

Meest populair

Premium

20 uur aan luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

Probeer 14 dagen gratis
Daarna € 9,99 / maand

Probeer gratis

Premium Plus

Onbeperkt luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

Probeer 14 dagen gratis
Daarna € 13,99 / maand

Probeer gratis

Alleen bij Podimo

Populaire luisterboeken

Veelgestelde vragen

Meer vragen & antwoorden
Probeer gratis

Probeer 14 dagen gratis. € 9,99 / maand na proefperiode. Elk moment opzegbaar.